MedPath
NMPA Approval

Methylprednisolone Sodium Succinate for Injection

国药准字H20133234

May 29, 2023

Drug Information

注射用甲泼尼龙琥珀酸钠

海思

注射剂

40mg(按C22H30O5计)

化学药品

May 29, 2023

Company Information

Applicant Company

兴城市曹庄工业园区

Manufacturing Company

辽宁省兴城市曹庄工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲泼尼龙琥珀酸钠 - NMPA 批准文号 | MedPath